| 1: Verner JV, Morrison AS. Islet cells tumor and a syndrome of refractory watery diarrhea and hypokalaemia. Am J Med 1958;25:374â380 [DOI via Crossref] | | | | 2: Bourdeaut F, de Carli E, Timsit S, et al. VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de I'Enfant (SFCE). Pediatr Blood Cancer 2009;52:585-590. [DOI via Crossref] [Pubmed] | | | | 3: Olgun N, Guneþ D, Aksoylar S, et al. The Turkish Pediatric Oncology Group Neuroblastoma 2003 (TPOG-NB-2003): Treatment results of the high risk group. 40th annual conference of the International Society of Paediatric Oncology SIOP 2008, Berlin, Germany. | | | | 4: Wildhaber B, Niggli F, Bergstrasser E, Stallmach T, Sacher P. Paraneoplastic sndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhea. Eur J Pediatr 2003;162: 511-513. [DOI via Crossref] [Pubmed] | | | | 5: Zhang WQ, Liu JF, Zhao J, Zhao SY, Xue Y. Tumor with watery diarrhoea, hpokalaemia in a 3 year-old girl. Eur J Pediatr 2009;168:859-862 [DOI via Crossref] [Pubmed] | | | | 6: Qualman SJ, O'Dorisio MS, Fleshman DJ et al. Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 1992;70:2005â2012. [DOI via Crossref] | | | | 7: Pence JC, Shorter NA. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res 1990;50:5177â5183 | | | | 8: Lamberts SWJ, Van Der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-54. [DOI via Crossref] [Pubmed] | | | | 9: Oda Y, Tanaka Y, Naruse T, Sasanabe R, Tsubamoto M, Funahashi H. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors, Surg Today 2002;32:690-694. | | |
|
|
